目的探讨周围神经病变的临床治疗方法优化方案的应用情况。方法选取本院2011年1月至2012年1月收治的周围神经病变患者189例,随机分为观察组95例,对照组94例,对照组患者应用常规治疗方案,观察组患者应用优化治疗方案,比较两组患者的临床治疗效果。结果对照组疗效优5例,疗效良68例,疗效差21例,疗效优良率为77.66%;观察组疗效优67例,疗效良22例,疗效差6例,疗效优良率为93.68%,观察组疗效优良率显著高于对照组,并具有显著差异(P0.05)。结论应用优化方案治疗周围神经病变具有确切的临床疗效,显著提高了治疗效果,改善了患者的生活质量,值得临床推广使用。

Objective To explore the clinical application of the treatment method of optimization scheme of peripheral neuropathy. Methods 189 patients with peripheral neuropathy in our hospital from 2011 January to 2012 January were randomly divided into the observation group of patients 95 cases, 94 cases in the control group, patients in the control group used routine treatment, patients in the observation group application optimization of treatment, compared two groups of patients with clinical curative effect. Results In the control group, the outcome was excellent in 5 cases, good in 68 cases curative effect, poor in 21 cases, the excellent and good rate was 77.66%;The curative effect of therapeutic group was excellent in 67 cases, effect 22 cases good, bad curative effect in 6 cases, the excellent and good rate was 93.68%, the curative effect of therapeutic group was signiifcantly higher than that of control group, the excellent and good rate, and has signiifcant difference (P<0.05). Conclu

目的：探讨蒙西医结合治疗急性胰腺炎的临床疗效。方法86例急性胰腺炎患者随机分为蒙西医组和西医组，观察两组的临床疗效及复发率。结果蒙西医组疗效优于西医组疗效。结论蒙西医结合治疗急性胰腺炎具有一定的疗效，能降低复发率，且应用方便，具有一定的实用性及推广价值。

Objective?To?study?the?clinical?effects?of?the?combined?treatment?of?the?Mongolian?medicine?and?western?medicine?for?acute?pancreatitis.?Methods?86?cases?of?AP?were?randomly?divided?into?Mongolian-western?medicine?therapy?group?and?western?medicine?therapy?group.?And?the?clinical?curative?effect?and?recurrence?rate?of?two?groups?were?observed.?Results?The?clinical?effects?of?the?Mongolian-western?medicine?therapy?group?were?better?than?the?western?medicine?therapy?group.?Conclusions?It?shows?the?advantages?of?the?clinical?effects?of?the?combined?treatment?of?the?Mongolian?medicine?and?western?medicine?in?decreasing?the?recurrence?rate?of?AP,?and?promoting?the?recovery.

目的：观察桂枝茯苓汤在不稳定性心绞痛瘀热相搏证患者的临床疗效。方法选择我院2012年4月至2013年6月期间收治的120例不稳定性心绞痛瘀热相搏证患者为对象，随机分为治疗组和对照组，治疗组患者共60例给予西药常规治疗，对照组共60例在西药常规治疗的基础上加服桂枝茯苓汤剂。四周为一个疗程，记录中医证候、心绞痛疗效、心电图疗效。结果治疗4周后，治疗组和对照组在中医症候疗效、心绞痛疗效、心电图疗效方面较治疗前均有明显改善；治疗后，治疗组在心绞痛疗效、心电图疗效、中医证候疗效方面明显优于对照组，组件比较存在显著差异，具有统计学意义（P<0.05或P<0.01）。结论桂枝茯苓汤能明显减少不稳定型心绞痛瘀热相搏证患者的心绞痛发作，改善患者心电图总有效率，提高患者中医证候疗效。

Objective To evaluate and study the effect of Guizhi Fuling decoction on the clinical efficacy of unstable angina patients with stagnated heat syndrome. Methods 120 unstable angina patients with stagnated heat syndrome admitted from april 2012 to June 2013 in our hospital were randomly divided into treatment group and control group. Patients in control group received the conventional standardized treatment of western medicine, while patients in the treatment group were given Guizhi Fuling decoction on the basis of the treatment in the control group, 4 weeks as a treatment course. The changes of TCM syndrome, the efficacy of angina and the changes of ECG were all observed in the two groups. Results: After 4 weeks treatment, the general efficacy on tcM symptoms, the angina symptom and the changes of ecG were improved significantly in two groups. However, these indexed were all improved better in treatment group than that in control group. The efficacy differences were statistic

目的系统评价红景天注射液治疗心绞痛的疗效及安全性。方法计算机检索Pub Med、Embase、Cochrane Library、CNKI、万方及VIP数据库中所有红景天注射液治疗心绞痛的疗效及安全性的随机对照研究,按照纳入和排除标准筛选文献、提取资料,并依据Cochrane Handbook 5.0.1的质量评价标准评价纳入研究的方法学质量。主要结果包括疾病疗效、心绞痛疗效、心电图疗效、中医证候总积分及不良反应。根据异质性检验结果选择固定效应模型或随机效应模型进行Meta分析。结果共纳入12个随机对照试验,合计1 442例患者。Meta分析主要结果显示:1红景天注射液+西医常规治疗组与西医常规治疗组比较,疾病疗效(RR=1.27,95%CI(1.09,1.48))、心绞痛疗效(RR=1.25,95%CI(1.14,1.38))及心电图疗效(RR=1.21,95%CI(1.10,1.34))差异均有统计学意义。2红景天注射液组与复方丹参注射液组比较,疾病疗效(RR=1.25,95%CI(1.04,1.50))、心电图疗效(RR=1.28,95%CI(1.09,1.50))及中医证候疗效(RR=1.09,95%CI(1.00,1.18))差异均有统计学意义,然而心绞痛疗效差异无统计学意义(RR=1.10,95%CI(0.92,1.32));与血塞通注射液组比较,心绞痛疗效(RR=1.08,95%CI(0.84,1.39))及心电图疗效(RR=1.13,95%CI(0.87,1.47))差异均无

Objective It is to systematically assess the clinical effectiveness and safety of rhadiola injection for angina pec-toris.Methods The databases such as PubMed,Embase,Cochrane Library,CNKI,WanFang and VIP were searched to collect all randomized control trials(RCTs)about the clinical effectiveness and safety of rhadiola injection for angina pectoris.Litera-tures were screened according to the inclusive and exclusive criteria,the data were extracted,the methodological quality of the included studies was assessed in line with Cochrane Handbook 5.0.1.The primary outcome measure including therapeutic effect, angina treatment effect, electrocardiogram ( ECG) curative effect, general integral of traditional Chinese medicine (TCM) symptoms and adverse drug reaction.The meta-analysis was performed with the fixed -effect model or random-effect model according to heterogeneity.Results Twelve RCTs with 1442 patients were included.The outcomes of meta-analyses showed that, ①rhadiola injec

观察自拟中药汤剂治疗社区获得性肺炎的临床疗效。方法:将40例纳入患者随机分为治疗组与对照组,每组20例,对照组予以常规西医治疗,治疗组在对照组基础上加服自拟中药汤剂,疗效结束后行疗效比较。结果:治疗组在临床疗效方面明显优于对照组(P0.05)。结论:自拟中药汤剂治疗社区获得性肺炎的疗效显著。

Objective: To observe clinical efficacy of TCM on community-acquired pneumonia. Methods: 40 patients were randomly divided into the treatment group and the control group, 20 cases for each. The control group was given western medicine, while the treatment group was given TCM medicine more. Results:Clinical efficacy in the treatment group was significantly better than that in the control group (P<0.05). Conclusion:Clinical efficacy of TCM medicine decoction was confirmed and significant.